Exploration of the evolutionary pattern of pathogenesis in liver cirrhosis with portal hypertension in traditional Chinese medicine

WANG Han, XIONG Zhuang, DENG Hou-bo, LIU Tie-jun, et al

Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases ›› 2024, Vol. 34 ›› Issue (8) : 673-676.

PDF(3961 KB)
PDF(3961 KB)
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases ›› 2024, Vol. 34 ›› Issue (8) : 673-676. DOI: 10.3969/j.issn.1005-0264.2024.008.001

Exploration of the evolutionary pattern of pathogenesis in liver cirrhosis with portal hypertension in traditional Chinese medicine

  • WANG Han, XIONG Zhuang, DENG Hou-bo, LIU Tie-jun, et al
Author information +
History +

Abstract

Portal hypertension is the most common and fatal complication of chronic liver disease, which falls under the category of "collateral disease" in Traditional Chinese Medicine(TCM). Due to the interconnectedness of the collaterals, the liver has a close relationship with the spleen, stomach, and the large and small intestines. Damp-heat and residual toxins are key factors in the formation of compensatory portal hypertension, while phlegm-dampness and blood stasis form its pathological foundation. The transmission of liver disease to the spleen is an inevitable process in the evolution from the compensatory phase to the decompensatory phase of liver cirrhosis. The depletion of blood and essence, and the mixing of clear and turbid substances are the intrinsic reasons for the exacerbation of portal hypertension in the decompensatory phase of liver cirrhosis,with common clinical complications such as hematemesis and ascites."Deficiency of the root and excess of the branch" is the overall characteristic of the pathogenesis of portal hypertension, and protecting the stomach qi is the foremost task in preserving the portal vein.

Key words

portal hypertension / liver cirrhosis / accumulative disease / bloating / pathogenesis law

Cite this article

Download Citations
WANG Han, XIONG Zhuang, DENG Hou-bo, LIU Tie-jun, et al. Exploration of the evolutionary pattern of pathogenesis in liver cirrhosis with portal hypertension in traditional Chinese medicine[J]. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, 2024, 34(8): 673-676 https://doi.org/10.3969/j.issn.1005-0264.2024.008.001

References

[1] 徐小元,丁惠国,令狐恩强,等.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].实用肝脏病杂志,2023,26(2):305-318.
[2] 李素云.明清西医东渐背景下经络理论的解读[J].中国针灸,
[3] 曹颖甫.经方实验录[M].朱俊,整理.北京:中国医药科技出版社,2014:8.
[4] 周丽丽,张春清.门静脉高压侧支循环与食管胃静脉曲张的关系[J].临床肝胆病杂志, 2023,39(9):2210-2216.
[5] 吴以岭.络病与血管病变的相关性研究及治疗[J].中医杂志,2006, 47(3):163-165.
[6] 吴以岭,贾振华,常丽萍,等.脉络学说营卫理论指导血管病变防治研究[J].中国实验方剂学杂志, 2019, 25(1):1-10.
[7] 于敏,南征,史耀勋,等.从中医“毒损肾络”论治慢性肾功能衰竭胰岛素抵抗[J].中医杂志,2009,50(7):585-587,591.
[8] 张磊,周雪忠,于剑,等.592例慢性乙型病毒性肝炎湿热证有效病例用药规律研究[J].中医杂志,2013,54(8):668-672.
[9] 亓民,张国强,王灵菊,等.当飞利肝宁胶囊联合替比夫定治疗慢性乙型肝炎34例[J].中医杂志,2012,53(20):1770-1772.
[10] 梁重峰.当飞利肝宁胶囊联合阿德福韦酯治疗慢性乙型肝炎75例[J].中医杂志,2011,52(16):1421-1422.
[11] 谢晶日,齐妍.非酒精性脂肪肝病中医药研究进展[J].辽宁中医药大学学报,2010,12(3):5-7.
[12] 海仁古丽·艾尔肯,谢晶日,梁国英.谢晶日教授治疗脂肪肝的经验总结[J].世界中西医结合杂志, 2020, 15 (9): 1654-1656,1679.
[13] 赵文霞,刘全忠,刘君颖,等.化痰利湿活血方加减治疗非酒精性脂肪性肝炎患者96例临床观察[J].中医杂志,2012,53(12):1025-1027.
[14] 区鸿斌,陶衔玥,金伟孝,等.“见肝之病,知肝传脾,当先实脾”理论及其临床应用[J].中医杂志,2012,53(9):797-799.
[15] 骆欢欢,王新华.从肝瘀正虚论肝纤维化治疗思路[J].中医杂志,2010,51(5):463-465.
PDF(3961 KB)

381

Accesses

0

Citation

Detail

Sections
Recommended

/